It’s important to remember that we will most likely have a large Pharma company making theses sales so as Moz has suggested in the past we will only get a percentage of these revenue figures after we receive an up front payment for a distribution and sales Chanel. Just trying to keep it real.
Some have also asked about partners etc. Because the drug is so good and the results have just about been proven it is in our best interests to go as far in to phase 3 without a partner as possible so we get a better deal. A lack of a partner right now is most likely by choice IMO.
Valuation and Targets, page-338
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.035(12.7%) |
Mkt cap ! $108.4M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 31.0¢ | 27.5¢ | $108.9K | 371.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 17420 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |